go back

Prostate Cancer Urine And PSA Risk Test

Alaska rates for HCPCS 0113U

Estimates the risk that a man has prostate cancer, to help decide whether a biopsy is warranted. It measures two RNA markers in urine, PCA3 and the TMPRSS2-ERG fusion, and combines them with the PSA protein level from blood into a single risk score.

Rates data updated July 2026.

Facilitymedian $2,818 · 10th–90th $759$5,8880%20%10th90th$2,818Professionalmedian $1,698 · 10th–90th $537$2,5700%20%10th90th$1,698$500.0$1.0K$2.0K$5.0K$10.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$1,905.46
Median
$5,495.41
Typical High
$8,912.51
Aetna
Setting
Professional
Modifier
Global
Typical Low
$537.03
Median
$2,570.40
Typical High
$2,570.40
Cigna
Setting
Facility
Modifier
Global
Typical Low
$2,089.30
Median
$2,089.30
Typical High
$2,089.30
Moda Health
Setting
Facility
Modifier
Global
Typical Low
$758.58
Median
$758.58
Typical High
$3,388.44
Moda Health
Setting
Professional
Modifier
Global
Typical Low
$758.58
Median
$758.58
Typical High
$2,454.71
Premera BCBS
Setting
Facility
Modifier
Global
Typical Low
$2,630.27
Median
$2,818.38
Typical High
$3,019.95
Premera BCBS
Setting
Professional
Modifier
Global
Typical Low
$1,148.15
Median
$1,698.24
Typical High
$1,698.24
Providence
Setting
Facility
Modifier
Global
Typical Low
$602.56
Median
$2,089.30
Typical High
$3,630.78
United
Setting
Professional
Modifier
Global
Typical Low
$457.09
Median
$758.58
Typical High
$2,290.87